INTRODUCTION
Focal adhesion kinase (FAK) is a widely expressed 125-kDa non-receptor cytoplasmic protein tyrosine kinase implicated in integrin-mediated signal transduction [1, 2] . In cells in culture, FAK localizes to focal adhesions. Activation of FAK by integrin clustering or by seven-transmembrane-domain receptors leads to the autophosphorylation of Tyr$*(, which allows the binding of the Src-homology 2 (SH2) domain of Src [3] , Fyn [4] or phosphatidylinositol 3-kinase [5] . The recruitment of Src-family kinases results in the phosphorylation of tyrosine residues in the catalytic (Tyr%!(, Tyr&(' and Tyr&(() [6] and C-terminal (Tyr)(" and Tyr*#&) regions of FAK [7, 8] . Phosphorylation of Tyr&(' and Tyr&(( increases FAK catalytic activity [6] . In some cells, the SH2 domain of Grb2 binds to phospho-Tyr*#& and triggers a Rasdependent activation of the mitogen-activated-protein-kinase (MAP kinase) pathway [7, 9] . The C-terminal region of FAK also contains two proline-rich sequences (PR1 and PR2), which provide binding sites for Src-homology-3 (SH3)-domain-containing proteins, including p130-cas [10, 11] , HEF [12] and GRAF [13] . In addition, the C-terminal extremity of FAK contains a sequence necessary and sufficient for focal adhesion-targeting (FAT) [14] and is associated with other proteins, including paxillin [15, 16] and talin [17] . The whole C-terminal region of FAK can be expressed autonomously in some cell types and play a regulatory role [18, 19] . Although several of the proteins associated with FAK are its substrates in itro, they are also good substrates for Src-family kinases, and it is unclear which proteins are directly phosphorylated by FAK in intact cells. The main function of FAK could rather be to recruit Src-family kinases and to serve as a regulated adapter protein. Thus activation of FAK by integrin clustering would result in the formation of active multimolecular complexes, triggering a number of signalling pathways (see [20] ). In contrast with the wealth of information accumulated on the properties of FAK C-terminal region, the function of the N-terminal domain of FAK is poorly understood. Recent sequence analysis has revealed that this domain of FAK is related to the band 4.1\ERM (ezrin\ radixin\moesin) domain and to the N-terminal domain of Janus kinases (JAKs) [21] . Many members of this domain superfamily, referred to as ' band 4.1\JEF ' (JAK\ERM\FAK), interact with transmembrane proteins [22] . Accordingly, it is known that the N-terminal domain of FAK binds to peptides derived from β-integrins intracellular sequences in itro [23] , although it plays no role in focal-adhesion targeting [14] . Thus the band 4.1\JEF N-terminal domain may rather be involved in the regulation of FAK [22, 24] . In brain, FAK is highly expressed [25] and is regulated by neurotransmitters (glutamate and acetylcholine), depolarization [26, 27] and lipid extracellular messengers such as endocannabinoids [28] and lysophosphatidic acid (LPA) [27] . Indirect evidence suggests that FAK is implicated in synaptic plasticity [29] , in ion-channel regulation [30] and possibly in other functions (see [24] for a recent discussion). In brain, FAK has a higher molecular mass than in other tissues [31, 32] , due to the presence of short peptides coded by alternative exons [32, 33] . In the absence of knowledge of the complete intron\exon organization of the FAK gene, we have suggested to term ' FAKj ' the isoforms which contain a three-amino-acid peptide (Pro-TrpArg) in the C-terminal region [28] and to refer to the isoforms with additional exons coding for peptides on either sides of Tyr$*( by a number indicating their length in amino acids (i.e. ' boxes ' 28, 6 and 7). (It should be noted that the presence of the exon coding for box 7 results also in a frameshift mutation that causes a Thr-to-Ala residue substitution [32] .) In the present study we refer to the various isoforms as follows : FAK0, isoform without additional exon FAKj, containing the Pro-Trp-Arg insert FAKj6, containing Pro-Trp-Arg and box 6
FAKj7, containing Pro-Trp-Arg and box 7 FAKj6,7, containing Pro-Trp-Arg and boxes 6 and 7
We have shown previously that the simultaneous presence of boxes 6 and 7 increases dramatically the autophosphorylation of FAK in transfected COS-7 cells, whereas the presence of ProTrp-Arg, or the additional presence of box 28, has no effect on autophosphorylation [32] . However, the respective role of boxes 6 and 7 in the increased autophosphorylation and its mechanism remained unknown. The aim of the present study was to dissect the expression pattern and the properties of the alternative exons of FAK independently. We used phosphorylation-state-specific antibodies to study in detail the phosphorylation of Tyr$*( in transfected COS-7 cells, which do not express naturally the variants of FAK, and provide a model system to determine the precise effects of the retention of exons characteristic of neuronal FAK on the properties of the protein. The results demonstrate that boxes 6 and 7 both contribute to dramatic alterations in the phosphorylation of Tyr$*(, increasing its autophosphorylation and preventing its transphosphorylation when co-expressed with Src-family kinases.
EXPERIMENTAL Antibodies
Serum SL38 was prepared by immunizing a rabbit against the Nterminal fragment of rat FAK (residues 1-376) expressed in Escherichia coli as a hexahistidine fusion protein [28] . SL41 was raised against a synthetic peptide encompassing residues 901-911 of FAKj [28] . Anti-phospho-Tyr$*( antibody S625857 was raised against a phosphorylated peptide encompassing residues 392-399 of rat FAK (SETDDYAET-CONH # ; the final T was added in place of the naturally occurring I to improve solubility without producing too short a peptide ; -CONH # is the amidated C-terminus), coupled to keyhole-limpet haemocyanin and affinity-purified as described in [34] , except that elution from the phosphopeptide affinity column was carried out at pH 2.6. Anti-FAK monoclonal antibody clone 77 (Mab77), raised against a peptide sequence encompassing residues 354-533, was from Transduction Laboratories, Lexington, KY, U.S.A.. Anti-FAK polyclonal antibodies A-17 directed against residues 2-18, and C-20 raised against residues 1033-1052, were from Santa Cruz Biotechnology Inc., Santa Cruz, CA, U.S.A. Anti-phosphotyrosine 4G10 monoclonal antibody was from Upstate Biotechnologies Inc., Lake Placid, NY, U.S.A. A hybridoma culture supernatant containing mouse monoclonal antibody VII F9 against vinculin was generously provided by Dr. M. Gloukhova (Institut Curie, Paris, France).
Subcloning and construction of FAK isoforms and mutated forms
We used a cDNA clone of FAKj6,7 obtained from a rat striatum cDNA library, encompassing 5h leader sequences E (49-75) and C (1-114) followed by nucleotides 400-4157 of rat FAKj sequence (GenBank2 accession no. AF02077) with the additional presence of exons described as box 6 and box 7 at positions 1608 and 1665 respectively [32, 33] . This FAKj6,7 clone was first placed into a pBlueScript vector (Stratagene, La Jolla, CA, U.S.A.) in which the Cla1 site in the polylinker had been deleted. FAKj6 was obtained by exchanging the Cla1-Nsi1 fragment of this clone for that of another FAKj cDNA clone obtained from the library screening, which did not contain box 7. This latter FAKj clone was also used as a template to synthesize a PCR fragment devoid of box 6, using primer oligonucleotides MF13 (5h GACCTGATCGATGGATACTGC-CGG 3h) and MF12 (5h AGGGCATGGTGTATGTGT 3h). The amplified DNA was digested with Sph1 and Cla1 and introduced into clones FAKj6 and FAKj6,7 at the corresponding restriction sites, giving rise to FAKj and FAKj7 subclones respectively. Using this strategy, all FAK subclones used in the present study included identical 5h and 3h untranslated regions. Mutated forms of FAK in which Tyr$*( was replaced by Phe were constructed with PCR fragments generated using primers MF13 and MF12YM (5h TCCTCATCGATGATCTCTGCAAAGTC-ATCTGT 3h) containing an A\T mismatch and introduced at the Sph1-Cla1 sites. For expression in COS-7 cells, the various FAK sequences were introduced into pBK-CMV2 vector, derived of pBK-CMV (Stratagene) by deletion of an Nhe1-Sal1 fragment corresponding to the bacterial promoter. Kinase-dead forms of FAK were generated by mutating Lys%&% to Arg using the QuickChange site-directed-mutagenesis kit (Stratagene) and oligonucleotide primers FAK-KR1 (5h TCCTCATCGATGA-TCTCTGCAAAGTCATCTGT 3h) and FAK-KR2 (5h TCCT-CATCGATGATCTCTGCAAAGTCATCTGT 3h). Sequences of the modified regions within all the FAK subclones and mutated forms were verified using the Thermosequenase sequencing procedure (Amersham). Fusion proteins in which green fluorescent protein (GFP) was placed at the N-terminus of FAK0, FAKj, or FAKj6,7 were constructed using pEGFP (Clontech). Mouse n-Src (a gift from Dr. D. Black, Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA, U.S.A.) or human Fyn (a gift from Dr. S. Roche, CNRS, Montpellier, France) were placed in pBK-CMV2. c-Src was constructed from n-Src by deletion of the neuronal-specific exon.
Cell culture and transfection
For biochemical experiments, COS-7 cells were grown in uncoated 100 mm-diameter culture dishes, transfected in the presence of polyethyleneimine [35] and lysed 48 h after transfection. The amount of DNA used per dish was 8 µg when FAK isoforms were transfected alone, or 7 µg of FAK and 1 µg of Srcfamily kinase DNA or of empty vector DNA for co-transfection experiments. For immunocytochemistry, we used a mouse fibroblast-like line generated as control for FAK-deficient cells [36, 37] and kindly provided by Dr. D. Ilic (Department of Stomatology and Anatomy, University of California, San Francisco, CA, U.S.A.). Cells were grown on uncoated 14 mmdiameter coverslips and transfected with 0.5 µg of plasmid DNA as described above. Primary cultures of neurons and astrocytes were as described previously [38] .
Immunoprecipitation, in vitro kinase assays and immunoblotting
Transfected COS-7 cells were homogenized in ice-cold nondenaturing buffer [20 mM Tris\HCl (pH 7.4)\2 mM EDTA], containing 1 mM sodium orthovanadate, 1 % (v\v) Nonidet P40 and protease inhibitors (Complete ; Boehringer). For in itro kinase assays, homogenates prepared in the absence of sodium orthovanadate were incubated for 10 min with the catalytic domain of the receptor-like protein tyrosine phosphatase (RPTP)-β phosphatase in fusion with glutathione S-transferase (GST-RPTP-β ; generously given by Dr. Janine Ragab, INSERM, Toulouse, France) coupled to glutathione-Sepharose beads. This treatment permitted removal of endogenous phosphate from tyrosine residues and possible associated SH2-containing proteins. Beads were removed by centrifugation, and FAKj was immunoprecipitated from the supernatants as described in [26, 28] . Immune precipitates kinase assays were carried out for 5 min at 25 mC in 50 µl of buffer containing 50 mM Hepes, pH 7.4, 10 mM MnCl # , 5 µM ATP and 5 µCi of [γ-$#P]ATP (3000 Ci\ mmol ; NEN Life Science Products). To study kinase activity of FAK, 50 µg of poly(Glu,Tyr) (4 : 1 ; Sigma) was added and samples were preincubated for 4 min at 25 mC prior to the addition of ATP. In some experiments the concentration of ATP was increased to 1 mM with non-radioactively labelled ATP. Samples were analysed by SDS\7 %-(w\v)-PAGE and autoradiography. Quantification was achieved by direct measurement of the radioactivity with an Instant Imager (Packard). Immunoblotting was carried out either from homogenates or from immune precipitates as described previously [26, 28] . In some experiments, tissue pieces or COS-7 cells were directly homogenized in a solution of 1 % SDS in water containing 1 mM sodium orthovanadate and immediately placed in a boiling-water bath. Following immunoblotting, antibodies were detected with a peroxidase-chemiluminescence method and quantified by computer-assisted scanning of the autoradiograms. Statistical analysis of data was carried out with one-way ANOVA followed by pairwise comparisons with Neuman-Keul's test.
Immunocytochemistry
At 17 h after transfection, cells on coverslips were fixed in 3.6 % paraformaldehyde, washed in PBS containing 0.2 % Triton X 100, and twice in PBS. Immunostaining for vinculin was carried out with VII F9 hybridoma culture supernatant diluted 1 : 2, affinity-purified biotinylated anti-mouse IgG (HjL) antibodies 1\750 (Vector Laboratories, Burlingame, CA, U.S.A.) and Texas Red-streptavidin 1 : 100 (Molecular Probes, Eugene, OR, U.S.A.). Staining of filamentous actin was carried out with 1 unit per coverslip of Alexa 594-phalloidin (Molecular Probes). Coverslips were mounted in 50 % Mowiol 4-88 (Calbiochem ; from France Biochem, Meudon, France). Images were acquired with a Provis Olympus fluorescence microscope and a digital chargecoupled-device camera (Princeton Instruments, Trenton, NJ, U.S.A.).
In situ hybridization
Horizontal sections of adult rat brains were prepared and hybridized as described previously [25] . Oligonucleotides were for FAK common sequence (GGACCGTTCCGTGCCAGTA-CCCAGGTGAGTCTTAGTACTCGAACTTGG [25] ), for the exon coding for box 6 (GTCTCGTCCCCACTAATTTC) and for the exon coding for box 7 (GGCTTCATCTATTCCAT-AGC). Oligonucleotides were labelled with [α-$$P]dATP (Amersham) and terminal transferase (Boehringer). In order to test the specificity of labelling, some sections were incubated with a 10-fold excess unlabelled oligonucleotide.
RESULTS

Alternative exons coding for boxes 6 and 7 are not uniformly distributed in rat brain
Studies with RT-PCR followed by Southern hybridization with exon-specific probes showed that the exon coding for box 7 is more widely expressed than that coding for box 6, since, besides brain, it is found at high levels in testis [32] . In brain, the two exons were detected in similar proportions in all regions, with the exception of cerebellum, in which the exon for box 7 was more abundant than the exon for box 6 [32] . To compare the expression patterns of these exons with more accuracy, we examined the distribution of FAK mRNA isoforms in rat brain using in situ hybridization with $$P-labelled oligonucleotides, assuming that, if the two exons were always retained simultaneously, they should give identical patterns. A 49-mer oligonucleotide complementary to a sequence of rat FAK mRNA common to all isoforms showed a widespread distribution of FAK transcripts in adult rat brain, and their relative enrichment in the hippocampus and the cerebral cortex ( Figure 1A ), as previously reported [25] . In contrast, hybridization with oligonucleotides specific for box 7 exon ( Figure 1B ) or box 6 exon ( Figure 1C ) gave distinct patterns. Box 7 exon appeared to be expressed rather diffusely in all brain regions ( Figure 1B ), whereas the oligonucleotide specific for box 6 exon generated a more contrasted pattern : hybridization was very high in the hippocampus, high in the cerebral cortex, intermediate in the striatum and not detectable in cerebellum ( Figure 1C) . In all cases, hybridization disappeared in the presence of a 10-fold molar excess of unlabelled oligonucleotides, demonstrating the specificity of the labelling ( Figures  1D, 1E and 1F ). Thus in situ hybridization revealed contrasts between the expression patterns of boxes 6 and 7 that were not detectable with reverse transcription (RT)-PCR, which averages the levels of transcripts in all cells. In addition, the differences between the levels of expression of boxes 6 and 7 in the cerebellum, although detected by RT-PCR [32] , appeared more striking, as visualized by in situ hybridization. These results reveal that, in some brain regions, box 7 is likely to be retained in the absence of box 6.
Expression of FAK splice isoforms in brain structures and in neurons and astrocytes in culture
Although migration of FAK0 and FAKj are identical [32] , three groups of FAK isoforms can be separated by size following electrophoresis in the presence of SDS on 7 % polyacrylamide gels : FAKj, FAKj6\FAKj7 and FAKj6,7 ( Figure 2A , Figure 2A, lanes 5 and 7) , whereas in astrocytic extracts it migrated as FAK0\j (lane 6).
Our attempts to raise specific antibodies against boxes 6 and 7 were unsuccessful. However, immunoblotting analysis revealed that a commercially available monoclonal antibody, Mab77, raised against amino acids 354-533 of FAK reacted very poorly with FAK isoforms containing either box 7 (FAKj7) alone or boxes 6 and 7 (FAKj6,7) ( Figure 2B, lanes 1-4) . Therefore we used the comparison of the immunoreactivity with Mab77 and with a polyclonal antibody reacting with all FAK isoforms (A-17) as an index of the presence of box 7 in FAK from various tissues and cell types ( Figure 2B, lanes 5-12) . A strong signal for FAK was obtained in all samples with A-17 ( Figure 2B, lanes 5-12) . In contrast, Mab77 reacted with FAK in liver and spleen ( Figure  2B, lanes 11 and 12) , but not in brain samples ( Figure 2B, lanes  5-7) , demonstrating the expression of FAK proteins containing box 7 in brain. In cerebellum, two bands with different molecular masses were observed, only the lower one being recognized by Mab77 ( Figure 2B, lane 8) . Although polyclonal antibody A-17 generated a good signal for FAK in astrocytes and neurons in primary culture, Mab77 detected readily FAK in astrocytes, but not in neurons ( Figure 2B , lanes 9 and 10). Altogether these results provide strong evidence that, in forebrain tissue and in neurons in culture, the main form of FAK contains boxes 6 and 7, as indicated by its size and its lack of reactivity with Mab77. In combination with previous results showing that the vast majority of brain FAK contains the Pro-Trp-Arg insertion [28, 39] , we conclude that the main isoform of FAK in forebrain neurones is FAKj6,7.
FAK isoforms have a similar intracellular targeting
One of the most characteristic properties of FAK is its targeting to focal adhesions [1, 2] . The FAT sequence responsible for this localization has been mapped to the C-terminus of the protein, between residues 853 and 1012 of the chicken sequence [14] . The Pro-Trp-Arg insertion of FAKj isoforms is located between residues 903 and 904 (rat sequence) [28, 33] and encompasses charged or bulky residues that could potentially disrupt the structure or the interactions of the FAT region. Therefore we examined whether FAKj could still be targeted to focal adhesions using fusion with GFP. In transfected fibroblast-like cells, FAK0-GFP was highly enriched in the peripheral part of focal adhesions, identified by simultaneous labelling for vinculin (Figures 3A and Ah) or for filamentous actin (Figures 3D and  3Dh) . A similar location was observed for FAKj-GFP ( Figures  3B, 3Bh, 3E and 3Eh ) and for FAKj6,7-GFP ( Figures 3C, 3Ch,  3F and 3Fh ). These results demonstrate that the presence of additional exons does not prevent the targeting of FAK neuronal isoforms to focal adhesions.
Phosphorylation-state-specific antibodies as a tool for measuring the phosphorylation of Tyr 397
To study autophosphorylation of FAK, an important step in its activation, we used affinity-purified antibodies (S625857) reacting only with FAK phosphorylated on Tyr$*(. Since these antibodies are a critical tool in the experiments presented below, we have characterized them in detail. The time course of in itro autophosphorylation of FAKj6,7 in immune precipitate kinase assays was similar whether it was measured by immunoblotting with affinity-purified S625857 antibodies or by detection of $#P
Figure 3 Intracellular targeting of the various isoforms of FAK
Mouse fibroblast-like cells were transfected with fusion proteins FAK0-GFP (A, Ah, D, and Dh), FAKj-GFP (B, Bh, E and Eh) or FAKj6,7-GFP (C, Ch, F and Fh). Intracellular localization of GFP was analysed 17 h after transfection (A-F). Double labelling was carried out with a monoclonal antibody against vimentin, revealed with biotinylated anti-mouse antibodies and Texas
Red-streptavidin (Ah-Ch) or Alexa 594-phalloidin to label filamentous actin (Dh-Fh).
incorporation in the same samples ( Figures 4A and 4B) . Conversely, incubation of transfected COS-7-cell homogenates with the phosphatase RPTP-β catalytic domain resulted in a very rapid decrease in phospho-Tyr$*( immunoreactivity, whereas the total amount of FAKj6,7 remained constant ( Figure 4C ). Finally, in homogenates from COS-7 cells transfected with various FAK isoforms, although numerous bands were labelled by anti-phosphotyrosine antibody 4G10, the affinity-purified S625857 antibodies reacted with a single 125 kDa band ( Figure  4D ). The observed immunoreactivity was increased by the presence of boxes 6 and 7, and unaltered by the presence of box 28 ( Figure 4D ), as already reported [32] .
Boxes 6 and 7 both contribute to the increased autophosphorylation of FAK neuronal isoforms in immune precipitates without marked alteration in their intrinsic kinase activity
The different patterns of expression of boxes 6 and 7 revealed by in situ hybridization prompted us to study their effects on FAK properties independently. We used transfected COS-7 cells to examine the properties of these isoforms in intact cells and as a source of material for in itro studies. Since these isoforms all contained the Pro-Trp-Arg insertion defining FAKj, which is absent from COS-7-cell endogenous FAK, they could be specifically recovered by immunoprecipitation with serum SL41 specific for FAKj [28] . In these experiments, cell lysates were pretreated with phosphatase RPTP-β to allow the comparative study of the intrinsic ability of FAK isoforms to autophosphorylate, independently of their level of phosphorylation in COS-7 cells. This phosphatase pretreatment resulted in a complete disappearance of FAK immunoreactivity for phosphoTyr$*( ( Figure 4C ) and for total phospho-Tyr (results not shown). Immune-precipitate-kinase assays showed that the presence of box 7 alone or box 6 alone increased $#P incorporation, as well as immunoreactivity for phospho-Tyr$*( ( Figure 5A, lanes 3  and 4) . The effects of the two boxes were additive ( Figure 5A and 5C). These experiments were carried out with a low concentration of ATP (5 µM) to provide a high $#P specific radioactivity. The phospho-specific antibodies allowed us to test whether the increased autophosphorylation could result from an increased affinity for ATP of FAKj with boxes 6 and\or 7. The results obtained with 1 mM ATP ( Figure 5B ) were identical with those with 5 µM (Figure 5A ), demonstrating that this was not the case.
We examined the effects of the presence of box 6 and\or 7 on the intrinsic kinase activity of FAK, using an exogenous substrate, poly(Glu,Tyr) (4 : 1). Although the activity of FAKj6,7 was significantly increased as compared with FAKj, this increase was very modest ($ 2-fold, Figure 5D ) as compared with the increase in autophosphorylation of the same isoform ($ 9-fold, Figure 5C ). To verify that the observed effects resulted from the autophosphorylation of FAK on Tyr$*( and not from the presence of a contaminating kinase and\or the phosphorylation of other tyrosine residue(s), we used mutated forms of FAK as controls. Mutation of Tyr$*( to Phe suppressed the autophosphorylation of FAKj and FAKj6,7 ( Figure 5A , lanes 1 and 6). Under our experimental conditions, in which FAK was dephosphorylated prior to the kinase assay, this mutation had no significant effect on the ability of FAKj to phosphorylate poly(Glu,Tyr) ( Figure 5D ). As expected, mutation of Lys%&% to Arg suppressed both autophosphorylation ( Figures  5A and 5C, lane 7) and phosphorylation of poly(Glu,Tyr)
Figure 4 Characterization of affinity-purified antibodies S625857 reacting specifically with FAK phosphorylated on Tyr
397
(A) Transfected COS-7 cells were homogenized in non-denaturing buffer and incubated for 10 min with RPTP-β. FAKj6,7 was immunoprecipitated with serum SL41. Equal amounts of immune precipitate were incubated for various times in the presence of 5 µM [γ-
32 P]ATP. Samples were resolved by SDS/PAGE, transferred to nitrocellulose and the same membrane was analysed by autoradiography (' 32 P-incorporation ') and immunoblotting with affinity-purified S625857 antibodies and chemiluminescence detection (' P-Tyr-397 '). Note that, in these experiments, a dephosphorylation occurred at the 10 min time point, due to the presence of a contaminating phosphatase. (B) 32 P incorporation was quantified with an Instant Imager and phospho-Tyr ( Figure 5D, bar 7) . Altogether these results show that Tyr$*( is the only tyrosine residue of FAK autophosphorylated in FAKj6,7.
Effects of boxes 6 and/or 7 on the phosphorylation of FAKj by Src-family kinases
Tyrosine phosphorylation of FAK is thought to occur generally in two steps : autophosphorylation of Tyr$*(, followed by the recruitment of Src-family kinases that phosphorylate additional tyrosine residues [3, 6] . We examined the consequences of the presence of boxes 6 and\or 7 on this cascade in intact cells. In transfected COS-7 cells, the total tyrosine phosphorylation of immunoprecipitated FAKj6,7 was much higher than that of FAKj ( Figure 6A, lanes 1 and 4) . Phosphorylation of FAKj6 or FAKj7 was intermediate between that of FAKj and of FAKj6,7 ( Figure 6A, lanes 2 and 3) . Mutation of Tyr$*( to Phe or of Lys%&% to Arg (kinase-dead mutant) decreased the total tyrosine phosphorylation of FAKj6,7 ( Figure 6A , lanes 5 and 6). However, in both mutants a low level of tyrosine phosphorylation was still observed, indicating that endogenous tyrosine kinases in COS-7 cells are capable of phosphorylating FAK in the absence of phosphorylation of Tyr$*(. Moreover, when c-Src was co-transfected with FAK, a strong tyrosine phosphorylation of all FAK isoforms was apparent ( Figure 6A, lanes 7-10) , as previously reported [32] . Interestingly, however, the Tyr$*( Phe or Lys%&% Arg mutants were also highly tyrosinephosphorylated under these conditions ( Figure 6A, lanes 11 and  12) . These results indicated that c-Src has the ability to phosphorylate FAK even in the absence of autophosphorylation of Tyr$*(. We studied the phosphorylation of Tyr$*( under the same experimental conditions ( Figure 6B ). When FAK was transfected alone, phosphorylation of Tyr$*( was higher in FAKj6,7 than in FAKj and intermediate in FAKj6 or FAKj7 ( Figure 6B,  lanes 2-5) . Phosphorylation of Tyr$*( was not detected in Tyr$*( Phe or kinase-dead (Lys%&% Arg) mutants ( Figure 6B, lanes  1, 6 and 7) . When c-Src was co-transfected with FAK, phosphorylation of Tyr$*( increased (lanes 9-12). As expected, no signal was detected for the Tyr$*( Phe mutant ( Figure 6B , lane 13). However, a surprising result was observed with kinasedead mutants : Tyr$*( was phosphorylated in the kinase-dead FAKj, but not in kinase-dead FAKj6,7 when they were cotransfected with c-Src ( Figure 6B, lanes 7 and 14) . This suggested that the presence of boxes 6 and\or 7 prevented phosphorylation of Tyr$*( by Src.
To explore further the effects of the alternative exons on phosphorylation of Tyr$*( by c-Src, we used kinase-dead mutants of all isoforms. The kinase-dead mutants of the various FAK isoforms did not appear to be phosphorylated on Tyr$*( when transfected alone in COS-7 cells ( Figure 6C, lanes 1-4) . When co- to Arg (kinase-dead mutant, K454R, lane 7). Homogenates were dephosphorylated with GST-RPTP-β and FAKj was immunoprecipitated. Pooled immune precipitates for each form of FAK were divided into several fractions used for the various assays described below. (A) One fraction was incubated for 5 min with 5 µM [γ-32 P]ATP (3000 Ci/ mmol). Samples were transferred to nitrocellulose and analysed for 32 P incorporation by autoradiography and for phosphorylation of Tyr 397 by imunoblotting with affinity-purified S625857 antibodies (' Immunoblot P-Tyr-397 '). A second fraction from each immune precipitate was used for determining the total amount of FAK (' Immunoblot FAK A-17 '). (B) A third fraction from each immune precipitate was incubated for 5 min in the presence of 1 mM unlabelled ATP and analysed by immunoblotting with affinity-purified S625857 antibodies (' Immunoblot P-Tyr-397 '). (C) Quantification of 32 P incorporation in the various FAKj isoforms and mutants during in vitro kinase assays, as in (A). Data correspond to the meanpS.E.M. for four experiments. Values were significantly different by ANOVA (F 6,14 l 13.36, P 10 − 4 ). Pairwise comparisons by Student-Newman-Keul's test showed that autophosphorylation of FAKj7 and FAKj6,7 was significantly higher than that of FAKj (P 0.05) and that autophosphorylation of FAKj6,7 was higher than that of FAKj6 or transfected with c-Src, kinase-dead FAKj was phosphorylated on Tyr$*( ( Figure 6C, lane 5) . Phosphorylation of Tyr$*( was weaker in kinase-dead FAKj6 or FAKj7, and was virtually abolished in kinase-dead FAKj6,7 ( Figure 6C , lanes 6-8, and Figure 6D ). Identical results were observed with the neuronal isoform of Src, n-Src, and with Fyn, which are both highly expressed in neurons (results not shown).
DISCUSSION
In vertebrates a single gene codes for FAK. The closest related kinase, PYK2\CAKβ, has only 45 % amino acid sequence identity [40, 41] and a markedly distinct expression pattern [39, 42] . The absence of functional redundancy of FAK and PYK2\CAKβ is demonstrated by the fact that FAK knockout mice die early during development [36] . A variety of FAK isoforms can be generated by the use of several promoters and of multiple alternatively spliced exons [18, 32, 33] . Several short exons coding for peptides of 3-28 amino acids are retained in FAK in brain. This may be linked to the preferential inclusion of small exons which has been suggested to occur during mRNA splicing in brain [43] . These exons are conserved in several species, indicating their functional importance : FAKj has been found in rat, mouse [33] , human [44] and Xenopus [45] ; boxes 6, 7 and 28 exist in rat and mouse [32] , and boxes 6 and 7 have also been reported in Xenopus [45] . We had already provided evidence that two exons coding for Pro-Trp-Arg, defining FAKj, and for box 7, respectively, are expressed in brain and testis, whereas those coding for box 6 and box 28 were found only in brain [28, 32, 33] . Isoforms containing box 28 appear to be expressed at very low levels in adult brain [32] . Additional alternative exons within the coding sequence may exist, but have not been characterized [33, 46] . The results reported here, in combination with our previous work [28, 32, 33] , show that although box 7 appears to be more widely expressed than box 6, the major isoform of FAK in rat forebrain, as well as in neurons in culture, is FAKj6,7. Interestingly, whereas FAKj is also found in astrocytes [33] , FAKj6, FAKj7 and FAKj6,7 were not detected in astrocytes (the present study).
These observations raise the question of the specific properties of neuronal FAK. Our data demonstrate that neither the presence of Pro-Trp-Arg in the FAT sequence, nor the insertion of peptides on either side of the autophosphorylated tyrosine, prevented targeting of FAK to focal adhesions in transfected cells. Although the functional consequences of the presence of Pro-Trp-Arg remain unknown, we show here that the presence of either box 6 or box 7 has dramatic consequences on the properties of FAK. The presence of these boxes increases FAK autophosphorylation in immune-precipitate assays and in transfected cells, in an additive manner. This effect is most likely due to a better accessibility of Tyr$*( to the catalytic site and not to a change in the intrinsic catalytic properties of the kinase domain, whose activity was only marginally increased in FAKj6,7 as compared with FAKj.
The present study demonstrates that the presence of boxes 6 and 7 altered the interactions of FAK with Src-family kinases. These interactions are complex, since Src can bind to FAK by both its SH2 and its SH3 domains. The SH2 domain binds to phosphorylated Tyr$*( [3, 47, 48] , and the SH3 domain binds to a peptide encompassing Pro$(" and Pro$(% [49] . Src binding results in its activation, leading to the phosphorylation of several additional tyrosine residues in the FAK sequence [6, 8] and in neighbouring proteins, triggering several signalling cascades. Thus, the interaction between FAK and Src has important consequences (see [20] for a discussion). Our results with an antibody specific for phospho-Tyr$*( and kinase-dead mutants of FAK clearly demonstrate that Src-family kinases, c-Src, n-Src, and Fyn, are capable of phosphorylating Tyr$*( in intact cells. This is perhaps not surprising, since Tyr$*( is located within a relatively good Src substrate sequence [50] . Interestingly, phosphorylation of Tyr$*( by Src was completely prevented by the simultaneous presence of boxes 6 and 7 in transfected cells. This effect could be due to a conformational change in neuronal isoforms of FAK, or to their interaction with other proteins, preventing the phosphorylation of Tyr$*( by Src-family kinases. It should be pointed out that recombinant Src added to FAK immune-precipitate assays phosphorylated Tyr$*( equally well in all isoforms (M. Toutant and J.-A. Girault, unpublished work). This indicates that the effects observed in transfected cells are due either to a conformational change in FAK, which is labile and lost in immune precipitates, or that the effect of Src-family kinases on phosphorylation of Tyr$*( is indirect and mediated by another kinase, a phosphatase or an interacting protein.
The physiological meaning of the direct phosphorylation of FAK by Src-family kinases is not known. It is possible that two pathways of interaction between Src and FAK exist in cells. In the ' classical ' scenario, FAK autophosphorylation is first activated by integrin engagement and\or stimulation of a G proteincoupled receptor, and, secondarily, quiescent Src becomes activated by its dual SH2 and SH3 interaction with FAK. In an alternative scenario, suggested by the present results, Src could be activated by another pathway, and could recruit FAK, not only by phosphorylating several residues in the catalytic and Cterminal domains, as previously reported [6] , but also by phosphorylating Tyr$*(, either directly or indirectly. This could lead either to a stronger interaction between Src and FAK, or to the recruitment and activation of additional Src molecules by providing binding sites for their SH2 domain. In this respect it should be kept in mind that FAK was originally identified as a protein highly phosphorylated on tyrosine in v-Src-transformed cells [1] . Our results suggest that, in neurons which express mostly (if not only) FAKj6,7, regulation of Tyr$*( phosphorylation by Src may not be possible, pointing towards an additional difference with the ubiquitous isoform.
In transfected COS-7 cells, as well as in immune-precipitate assays, FAKj6,7 is highly phosphorylated on tyrosine, whereas the phosphorylation of FAK0 or FAKj is very low. This high degree of phosphorylation of FAKj6,7 suggests that this isoform behaves as a constitutively activated form of FAK. However, it is clear that FAKj6,7 is still tightly regulated in cells. First, the high degree of phosphorylation of FAKj6,7 in COS-7 cells was dependent on cell attachment, since it was markedly decreased 30 min after cells had been placed in suspension (M. Toutant, M. Gelman and J.-A. Girault, unpublished work). Secondly, in hippocampal slices, phosphorylation of FAKj6,7 is low under basal conditions and increases dramatically in response to neurotransmitters or neuromodulators [26, 28] . The contrast between the levels of phosphorylation of FAKj6,7 in transfected non-neuronal cells and in nervous tissue suggests that specific regulatory mechanisms controlling FAK activation may exist in neurons. One such mechanism could be the existence of protein tyrosine phosphatase(s) lowering the level of tyrosine phosphorylation of FAK under basal conditions and that could be subject to regulation by extracellular messengers. Thus a high turnover rate of the phosphate on Tyr$*(, resulting from very active autophosphorylation and dephosphorylation, could account for the high responsiveness of FAK to neurotransmitters or endocannabinoids and may provide an original pathway for coupling rapid events to changes of longer duration in the nervous system. A. C. was supported by a fellowship from the Ministe' re des Relations Exte! rieures. This work was in part supported by a Biotech grant from the European Commission
